CD8-α (C8/144B) Antibody sc-53212 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCD8-α (C8/144B) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-53212
Antibody TypePrimary Antibodies
NCBI Gene Aliasesp32, CD8alpha, Leu2, CD8
Quantity200 µg/ml
CloneC8/144B
Reactivityhuman
ApplicationsWB, IP, IF, IHC(P)
Hostmouse
Conjugate/TagUnconjugated
ClonalityMonoclonal
FormatPurified
NCBI Full Gene NameCD8 subunit alpha
TargetCD8-alpha
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHDCell reports. MedicineJuly 18, 2023Jarosch S, Köhlen J, Ghimire S, Orberg ET, Hammel M, Gaag D, Evert M, Janssen KP, Hiergeist A, Gessner A, et al.

(2) Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loopCancer cellDecember 12, 2022Hua Y, Vella G, Rambow F, Allen E, Antoranz Martinez A, Duhamel M, Takeda A, Jalkanen S, Junius S, Smeets A, et al.

(3) VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8(+) T cell killing in colorectal cancereLifeDecember 2, 2022Yang L, Dong X, Liu Z, Tan J, Huang X, Wen T, Qu H, Wang Z.

(4) Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory MarkersDiagnostics (Basel, Switzerland)November 14, 2022Razaghi A, Szakos A, Alouda M, Bozóky B, Björnstedt M, Szekely L.RRID: AB_2819099, clone SP263 catalogue # 07494190001, Ventana) and (Santa Cruz Biotechnology Cat# sc-53212, RRID: AB_1120718, clone C8/144B catalogue # M7103, Dako, Agilent), respectively. 2.6. Statistical

(5) PD1(+)CD8(+) Cells Are an Independent Prognostic Marker in Patients with Head and Neck CancerBiomedicinesNovember 3, 2022Pokrývková B, Grega M, Klozar J, Vencálek O, Nunvář J, Tachezy R.

(6) Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosisArthritis research & therapyJune 21, 2022Zhang L, Zheng D, Yan Y, Yu Y, Chen R, Li Z, Greer PA, Peng T, Wang Q.

(7) ChipCytometry for multiplexed detection of protein and mRNA markers on human FFPE tissue samplesSTAR protocolsJune 17, 2022Jarosch S, Köhlen J, Wagner S, D'Ippolito E, Busch DH.

(8) Multiplexed imaging and automated signal quantification in formalin-fixed paraffin-embedded tissues by ChipCytometryCell Rep MethodsNovember 22, 2021Jarosch S, Köhlen J, Sarker RSJ, Steiger K, Janssen KP, Christians A, Hennig C, Holler E, D'Ippolito E, Busch DH.4°C,surface GATA-3,PE,FS560,L50-823,mouse,BD Pharmingen,560074,1:50,o.n. 4°C,intranuclear CD8,PE,FS560,C8/144B,mouse,Santa Cruz,sc53212 PE,1:50,o.n. 4°C,surface CD20,PE,FS560,H1,mouse,BD Bioscience,561174,1:200,o.n. 4°C,surface CD45RO,PE,FS560,UCHL1,mouse,BioLegend,304206,1:150,o.n.

(9) Antibodies validated for routinely processed tissues stain frozen sections unpredictablyBioTechniquesMarch 1, 2021Bolognesi MM, Mascadri F, Furia L, Faretta M, Bosisio FM, Cattoretti G.

(10) STAT3 Activation-Induced Fatty Acid Oxidation in CD8⁺ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor GrowthCell metabolismJanuary 7, 2020Zhang C, Yue C, Herrmann A, Song J, Egelston C, Wang T, Zhang Z, Li W, Lee H, Aftabizadeh M, et al.Cruz Biotech,Cat# sc-08022 RRID: AB_2232723 CD8-α Antibody (clone C8/144B),Santa Cruz Biotech,Cat# sc-53212 RRID: AB_1120718 Rabbit polyclonal anti-STAT3,Santa Cruz Biotech,Cat# sc-482; RRID: AB_632440 Normal rabbit IgG

(11) Flex-Array® - a novel multi-well vessel system for the immobilization and multi-modal testing of intact formalin-fixed paraffin-embedded (FFPE) cells or tissuesJournal of histotechnologyDecember 1, 2019Genty C, McDonnell TJ.

(12) Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillanceNatureJanuary 4, 2018Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, Tan Y, Ci Y, Wu F, Dai X, et al.

(13) Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer stainingJournal of immunology (Baltimore, Md. : 1950)July 15, 2011Clement M, Ladell K, Ekeruche-Makinde J, Miles JJ, Edwards ES, Dolton G, Williams T, Schauenburg AJ, Cole DK, Lauder SN, et al.

(14) Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradationJournal of immunology (Baltimore, Md. : 1950)February 15, 2009Fernandez DR, Telarico T, Bonilla E, Li Q, Banerjee S, Middleton FA, Phillips PE, Crow MK, Oess S, Muller-Esterl W, et al.agarose beads coupled to HRES-1/Rab4-GST. Antibodies to CD2AP (sc-25272), TCR/CD3ζ (sc-1239), CD8 (sc-53212) and Rab5A (sc-28570) were obtained from Santa Cruz. The results represent four independent experiments.

Be the First to Write a Review!

CD8-α (C8/144B) Antibody

CD8-α (C8/144B) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (14)

Reviews

CD8-α (C8/144B) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map